70. Spinal stenosis Clinical trials / Disease details

Clinical trials : 95 / Drugs : 169 - (DrugBank : 61) / Drug target genes : 68 - Drug target pathways : 90

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03011866 (ClinicalTrials.gov)	February 2017	16/12/2016	Tranexamic Acid in Reducing Gross Hemorrhage and Transfusions of Spine Surgeries	Intravenous Versus Topical Use of Tranexamic Acid in Reducing Gross Hemorrhage and Transfusions of Spine Surgeries (TARGETS) : A Prospective, Randomized, Double Blind, Head-to-head Comparison Study	Spinal Stenosis;Intervertebral Disc Displacement	Drug: Wound topically irrigated with 500mg TXA;Drug: 1mg/kg/hr TXA intravenous infusion till the last suture	Peking Union Medical College Hospital	NULL	Not yet recruiting	50 Years	N/A	All	176	N/A	NULL
2	NCT02063035 (ClinicalTrials.gov)	August 2012	19/12/2013	Effectiveness Study of the Drug Tranexamic Acid to Reduce Post-surgery Blood Loss in Spinal Surgery	Topical Application of Tranexamic Acid to Reduce Postoperative Blood Loss in Posterior Approach Spinal Surgery	Lumbar Spinal Stenosis;Thoracic Spinal Stenosis	Drug: Tranexamic Acid;Drug: Placebo	Massachusetts General Hospital	NULL	Completed	18 Years	85 Years	All	29	Phase 4	United States